Extracorporeal membrane oxygenation in COVID-19: a case report
Introduction: The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2022
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/29337 |
| Aporte de: |
| Sumario: | Introduction: The role of the use of Extracorporeal Membrane Oxygenation (ECMO) in patients with coronavirus disease (COVID-19) is under discussion. Whereas in patients with Acute Respiratory Distress Syndrome (ARDS) the ECMO is a usual rescue measure used to optimize the oxygenation as a bridge to pulmonary rehabilitation, in patients that have refractory hypoxemic respiratory failure with recovery potential, the use of ECMO could also be beneficial.
Objective: The purpose of this work is to report the first case of COVID-19 that required ECMO in Argentina, with a good response.
Methodology: We describe the first case of COVID-19 that required ECMO in Argentina, in a patient without comorbidities, with good clinical results.
Results: The use of ECMO in the reported case provided a substantial benefit in oxygenation, acting as a bridge to lung recovery, without presenting complications associated with its application.
Conclusion: In critically ill patients with refractory hypoxemia, but with high recovery potential, ECMO support can be considered as a rescue measure. |
|---|